1. Signaling Pathways
  2. Immune Checkpoint

Immune Checkpoint

Immune checkpoints are molecules in the immune system that regulate immune responses. Immune checkpoints ensure that the immune system attacks foreign pathogens (such as bacteria, viruses, etc.) without excessively damaging normal tissues (maintaining self-tolerance, preventing autoimmune responses, etc.). Therefore, immune checkpoints will be used by some tumor cells or pathogens of infectious diseases to escape immune attack. Therefore, immune checkpoint inhibitors are increasingly used in cancer immunotherapy. Immune checkpoint inhibitors can enhance the immune system's attack on tumor cells, or block inhibitory checkpoints (such as CTLA-4, PD-1), thereby restoring effective T cell function. Overall, immune checkpoints are a biological mechanism that regulates immune responses, and are of great significance for the normal function of the immune system and the development of immunotherapy.

Immune Checkpoint Related Products (1):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-P99117
    Cadonilimab
    99.29%
    Cadonilimab (AK104) is a humanized tetravalent IgG1 bispecific antibody targeting PD1/CTLA4. Cadonilimab blocks both PD-1 and CTLA-4 pathways, thereby relieving their corresponding immunosuppressive effects and reversing tumor specific T cell exhaustion. Cadonilimab significantly downregulates Fc-mediated effector functions, including antibody-dependent cell-mediated cytotoxicity (ADCC), antibody-dependent cellular phagocytosis (ADCP), complement dependent cytotoxicity (CDC). Cadonilimab can be used for research of metastatic cervical cancer, as well as other malignancies such as gastric cancer, GEJ adenocarcinoma and non-small cell lung cancer (NSCLC).
    Cadonilimab